(Q43838827)

27 November 2017

Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin (English)

1 reference

27 November 2017

1 reference

1 reference

R Frothingham

1

1 reference

PubMed ID

11765299

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

21

1 reference

27 November 2017

1468-1472

1 reference

27 November 2017

12

1 reference

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

27 November 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1468.34482

Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1468.34482

Avoidance of ingestion of anti-inflammatory drugs in dyspepsia is confounding variable

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1468.34482

New milestones achieved in fluoroquinolone safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1468.34482

Comparative tolerability of the newer fluoroquinolone antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1468.34482

10.1592/PHCO.21.20.1468.34482

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11765299